Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Clinical and demographical characteristics of renal allograft recipients (n = 211) prior to transplantation

From: A very low thymus function identifies patients with substantial increased risk for long-term mortality after kidney transplantation

Age in years, median (range)

57 (19–79)

Male/female

62–38%

Follow-up time in months, median (range)

74 (0–97)

Living kidney donor, n (%)

211 (100%)

Previous kidney transplant, n (%)

19 (9.0%)

Pre-emptive transplantation, n (%)

91 (43.1%)

Anti-rejection therapy

39 (18.4%)

T cell depleting therapy for rejection

18 (8.5%)

Cardiovascular disease prior to transplantation, n (%)

53 (25.1%)

Distribution of underlying kidney disease

Nephrosclerosis/hypertension

22.7%

 Primary glomerulopathies

13.7%

 Diabetes mellitus

19.9%

 Urinary tract infections/ stones

2.8%

 Reflux nephropathy

4.7%

 Polycystic kidney disease

19.0%

 Other

11.8%

 Unknown

5.2%

 CMV seropositive*

59%

 Recipients deceased during follow-up

30

Cause of death

 cardiovascular disease

20.0%

 infection

26.7%

 cancer

26.7%

 other

3.3%

 unknown

23.3%